Neurological complications in renal failure: a review

被引:248
作者
Brouns, R
De Deyn, PP [1 ]
机构
[1] Middleheim Gen Hosp, Dept Neurol & Memory Clin, Antwerp, Belgium
[2] Univ Antwerp, Born Bunge Fdn, Neurochem Lab, B-2610 Antwerp, Belgium
关键词
renal failure; uremia; dialysis; renal transplantation; encephalopathy; neuropathy; myopathy;
D O I
10.1016/j.clineuro.2004.07.012
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Neurological complications whether due to the uremic state or its treatment, contribute largely to the morbidity and mortality in patients with renal failure. Despite continuous therapeutic advances, many neurological complications of uremia, like uremic encephalopathy, atherosclerosis, neuropathy and myopathy fail to fully respond to dialysis. Moreover, dialytic therapy or kidney transplantation may even induce neurological complications. Dialysis can directly or indirectly be associated with dialysis dementia, dysequilibrium syndrome, aggravation of atherosclerosis, cerebrovascular accidents due to Ultrafiltration-related arterial hypotension, hypertensive encephalopathy, Wernicke's encephalopathy, hemorrhagic stroke, subdural hematoma, osmotic myelinolysis, opportunistic infections, intracranial hypertension and mononeuropathy. Renal transplantation itself can give rise to acute femoral neuropathy, rejection encephalopathy and neuropathy in graft versus host disease. The use of immunosuppressive drugs after renal transplantation can cause encephalopathy, movement disorders, opportunistic infections, neoplasms, myopathy and progression of atherosclerosis. We address the clinical, pathophysiological and therapeutical aspects of both central and peripheral nervous system complications in uremia. (C) 2004 Elsevier B.V. All rights reserved.
引用
收藏
页码:1 / 16
页数:16
相关论文
共 220 条
[11]   Neurotoxicity of calcineurin inhibitors: impact and clinical management [J].
Bechstein, WO .
TRANSPLANT INTERNATIONAL, 2000, 13 (05) :313-326
[12]   Familial clustering of ruptured intracranial aneurysms in autosomal dominant polycystic kidney disease [J].
Belz, MM ;
Hughes, RL ;
Kaehny, WD ;
Johnson, AM ;
Fick-Brosnahan, GM ;
Earnest, MP ;
Gabow, PA .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2001, 38 (04) :770-776
[13]   ACUTE NEUROLOGIC COMPLICATIONS OF HEMODIALYSIS - STUDY OF 14,000 HEMODIALYSES IN 103 PATIENTS WITH CHRONIC-RENAL-FAILURE [J].
BENNA, P ;
LACQUANITI, F ;
TRIOLO, G ;
FERRERO, P ;
BERGAMASCO, B .
ITALIAN JOURNAL OF NEUROLOGICAL SCIENCES, 1981, 2 (01) :53-57
[14]   Acute aluminum encephalopathy in a dialysis center caused by a cement mortar water distribution pipe [J].
Berend, K ;
van der Voet, G ;
Boer, WH .
KIDNEY INTERNATIONAL, 2001, 59 (02) :746-753
[15]   PERITONEAL-DIALYSIS - TEMPORIZING MEANS FOR HEMODIALYSIS PATIENTS WITH SUBDURAL HEMATOMAS [J].
BIDWELL, G ;
SHERRARD, D ;
MATHEWS, M .
NEPHRON, 1977, 18 (06) :352-353
[16]   Intrathecal saline infusion in the treatment of obtundation associated with spontaneous intracranial hypotension: Technical case report [J].
Binder, DK ;
Dillon, WP ;
Fishman, RA ;
Schmidt, MH .
NEUROSURGERY, 2002, 51 (03) :830-836
[17]   ELECTROPHYSIOLOGIC CHANGES IN UREMIC NEUROPATHY AFTER SUCCESSFUL RENAL-TRANSPLANTATION [J].
BOLTON, CF .
NEUROLOGY, 1976, 26 (02) :152-161
[18]   Interferon-alpha and the cure of metastasis of a malignant meningioma in a kidney allograft recipient: A case report [J].
Bosmans, JL ;
Ysebaert, D ;
DeCock, AM ;
Hauben, E ;
Muylle, L ;
Schrijvers, D ;
VanMarck, E ;
Eyskens, E ;
DeBroe, ME .
TRANSPLANTATION PROCEEDINGS, 1997, 29 (1-2) :838-838
[19]   Controlled comparison of l-5-methyltetrahydrofolate versus folic acid for the treatment of hyperhomocysteinemia in hemodialysis patients [J].
Bostom, AG ;
Shemin, D ;
Bagley, P ;
Massy, ZA ;
Zanabli, A ;
Christopher, K ;
Spiegel, P ;
Jacques, PF ;
Dworkin, L ;
Selhub, J .
CIRCULATION, 2000, 101 (24) :2829-2832
[20]   Addition of sertraline to other therapies to reduce dialysis-associated hypotension [J].
Brewster, UC ;
Ciampi, MA ;
Abu-Alfa, AK ;
Perazella, MA .
NEPHROLOGY, 2003, 8 (06) :296-301